Logo

American Heart Association

  2
  0


Final ID: Mo4170

Impact of myocardial infarction on aortic and mitral bioprosthetic valve degeneration

Abstract Body (Do not enter title and authors here): Background. Studies have previously suggested that myocardial infarction (MI) have an impact on native aortic valve stenosis progression as well as inducing pathobiological changes in native mitral and tricuspid native valve leaflets. Inflammation, renal failure, and hypertension have been identified as potential factors accelerating structural valve degeneration (SVD). However, the impact of MI on bioprosthetic valve and SVD is unknown.
Hypothesis. MI accelerates the progression of bioprosthetic valve degeneration.
Methods. A retrospective cohort analysis of patients who underwent a bioprosthetic aortic or mitral valve replacement at Quebec Heart and lung Institute was done. Patients were identified through a keyword search in institutional medical records and through the local cardiac surgical database (n = 158). Inclusion required a bioprosthetic valve in aortic (n = 146) or mitral (n = 12) position, with or without history of MI after surgery and at least two echocardiograms within 5 years post-MI, along with available echocardiograms performed ≥6 months prior to the MI. Patients were matched for baseline and prosthetic valve characteristics and divided into two groups 1) No MI (controls, n= 79), 2) MI (cases, n= 79). Echocardiograms were reviewed for valve mean and maximal gradient as well as valve area derived from the continuity equation.
Results. At baseline, the two matched groups had comparable characteristics and echocardiographic data. The annualized progression of prosthetic valve area was higher in the MI group (-0.04 ± 0.16 cm2/y vs 0.00 ± 0.11, p = 0.039). This was mostly driven by patients with aortic valve replacement (aortic valve area -0.05 ± 0.14 cm2/y vs 0.01 ± 0.11, p = 0.0077). Using a mixed linear model, the presence of MI had a significant interaction with the decline of aortic valve area and indexed aortic valve area (p = 0.0057, p = 0.0041). There was no difference in mean or maximal gradient between the two matched group. Annual progression rate of indexed bioprosthetic aortic valve area was faster in men compared to women in the whole population (-0.061 ± 0.01 cm2/m2/y vs -0.01 ± 0.02 cm2/m2/y for men and women, respectively; p = 0.009).
Conclusion. This study suggests that bioprosthetic valve stenosis may be accelerated following a myocardial infarction. These findings could be explained by the same fibrotic mechanisms observed in native valves. More studies are needed to understand the underlying mechanisms and clinical impact.
  • Rouabhia, Dounia  ( Quebec Heart and Lung Institute , Quebec , Quebec , Canada )
  • Desroches, Florence  ( Quebec Heart and Lung Institute , Quebec , Quebec , Canada )
  • Paquin, Amelie  ( Quebec Heart and Lung Institute , Trois-Rivieres , Quebec , Canada )
  • Mohammadi, Siamak  ( Quebec Heart and Lung Institute , Quebec City , Quebec , Canada )
  • Clavel, Marie-annick  ( QUEBEC HEART INST , Quebec , Quebec , Canada )
  • Pibarot, Philippe  ( IUCPQ-UL , Quebec , Quebec , Canada )
  • Beaudoin, Jonathan  ( Quebec Heart and Lung Institute , Quebec , Quebec , Canada )
  • Author Disclosures:
    Dounia Rouabhia: DO NOT have relevant financial relationships | Florence Desroches: No Answer | Amelie Paquin: DO NOT have relevant financial relationships | Siamak Mohammadi: DO NOT have relevant financial relationships | Marie-Annick Clavel: DO have relevant financial relationships ; Research Funding (PI or named investigator):Edwards Lifesciences:Past (completed) ; Research Funding (PI or named investigator):Pi-Cardia:Past (completed) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) | Philippe Pibarot: DO have relevant financial relationships ; Research Funding (PI or named investigator):Edwards Lifesciences:Active (exists now) ; Research Funding (PI or named investigator):Cardiac Success:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) ; Research Funding (PI or named investigator):Pi-Cardia:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) | Jonathan Beaudoin: DO have relevant financial relationships ; Research Funding (PI or named investigator):JAMP Pharma:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Advanced Approaches in Valvular Disease: From Biomechanics to Clinical Practice

Monday, 11/18/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
Contemporary Diagnosis, Management, and Outcomes of Patients With Low-Gradient Severe Aortic Stenosis: A Multi-Center Analysis

Vemulapalli Sreekanth, Genereux Philippe, Lindman Brian, Elmariah Sammy, Pibarot Philippe, Peterson Benjamin, Rodriguez Evelio, Leon Martin, Mack Michael, Eberst Kyle

Cross-Platform Variations in Transthoracic Echocardiography: Implications for Clinical Decision-Making

Hashemi Mohammad, Farsiani Yasaman, Pressman Gregg, Amini Mohammadreza, Kheradvar Arash

More abstracts from these authors:
Sex difference in Prosthesis-Patient Mismatch after Surgical Aortic Valve Replacement and long-term clinical outcome

Springhetti Paolo, Abdoun Kathia, Dumont Eric, Dagenais Francois, Kalavrouziotis Dimitri, Mohammadi Siamak, Pibarot Philippe, Clavel Marie-annick

Native aortic stenosis progression: a focus on sex differences.

Springhetti Paolo, Abdoun Kathia, Powers Andreanne, Tastet Lionel, Beaudoin Jonathan, Pibarot Philippe, Clavel Marie-annick

You have to be authorized to contact abstract author. Please, Login
Not Available